Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

JDP Therapeutics Inc.

www.jdptherapeutics.com

Latest From JDP Therapeutics Inc.

Novartis Targets Chronic Urticaria As Ligelizumab Enters Late-Stage Trials

Two Phase III studies, PEARL 1 and PEARL 2, will compare Novartis's candidate anti-IgE antibody with the previous generation anti-IgE MAb, Xolair, for the treatment of chronic spontaneous urticaria.

 

Dermatology Clinical Trials

Pipeline Watch: Top-Line Fremanezumab, Ramucirumab, Bictegravir Results

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

JDP Therapeutics Inc.

JDP Therapeutics Inc. is working to reformulate an off-patent oral drug into an injectable form that will treat the peripheral, non-life-threatening symptoms of acute allergic reactions to substances such as peanuts and seafood. The benefit envisioned? Fewer side effects than the IV Benadryl currently given to relieve body swelling and itching.

Start-Up Previews (09/2011)

This Month's Profile Group: Cartilage Repair: Opportunities In Motion-Preserving Orthopedics, features profiles of Articulinx, Carticept Medical and Orthox. Plus these Start-Ups Across Health Care: Ellipse Technologies, JDP Therapeutics, NuMe Health and SironRX Therapeutics.
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Immune Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • JDP Therapeutics Inc.
  • Senior Management
  • Jie Du, PhD, Pres. & CEO
    John M Morrash, CFO
  • Contact Info
  • JDP Therapeutics Inc.
    823 Jays Dr.
    Lansdale, PA 19446
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register